Walker Matthew Allen's Form 4 filing
GreenLight Biosciences Holdings, PBC (GRNA) · filed Aug 15, 2022
- Accession no.
- 0001062993-22-018004
- Filed
- Aug 15, 2022
- Trade date
- Aug 11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $25.2M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker Matthew AllenCIK 0001908721 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Consists of 63,775 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and Matthew Allen Walker.
Referenced by the price of 1 transaction in Table I.
- F2
Includes 6,377,551 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, LP ("Fund III").
Referenced by the price of 1 transaction in Table I.